Severe late esophagus toxicity in NSCLC patients treated with IMRT and concurrent chemotherapy
Author:
Publisher
Elsevier BV
Subject
Radiology, Nuclear Medicine and imaging,Oncology,Hematology
Reference19 articles.
1. Acute esophagus toxicity in lung cancer patients after intensity modulated radiation therapy and concurrent chemotherapy;Kwint;Int J Radiat Oncol Biol Phys,2012
2. Dose escalation for non-small cell lung cancer: analysis and modelling of published literature;Partridge;Radiother Oncol,2011
3. Prognostic parameters for acute esophagus toxicity in intensity modulated radiotherapy and concurrent chemotherapy for locally advanced non-small cell lung cancer;Uyterlinde;Radiother Oncol,2013
4. Association between single nucleotide polymorphisms of the transforming growth factor β1 gene and the risk of severe radiation esophagitis in patients with lung cancer;Guerra;Radiother Oncol,2012
5. Response, toxicity, failure patterns, and survival in five Radiation Therapy Oncology Group (RTOG) trials of sequential and/or concurrent chemotherapy and radiotherapy for locally advanced non-small-cell carcinoma of the lung;Byhardt;Int J Radiat Oncol Biol Phys,1998
Cited by 47 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Excessive esophageal toxicity in patients with locally advanced non-small cell lung cancer treated with concurrent hypofractionated chemoradiotherapy and 3-weekly platinum doublet chemotherapy;Clinical and Translational Radiation Oncology;2022-09
2. Avoiding Toxicity With Lung Radiation Therapy: An IASLC Perspective;Journal of Thoracic Oncology;2022-08
3. Radiotherapy for primary lung cancer;Cancer/Radiothérapie;2022-02
4. Toxicity after volumetric modulated arc therapy for lung cancer: a monocentric retrospective study;Translational Lung Cancer Research;2021-01
5. Phase I and Pharmacologic Study of Olaparib in Combination with High-dose Radiotherapy with and without Concurrent Cisplatin for Non–Small Cell Lung Cancer;Clinical Cancer Research;2020-12-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3